Micah Fisher MD
Overview
Dr. Fisher is a graduate of the Wake Forest University School of Medicine. He received training in Internal Medicine at the University of Pennsylvania before going to Johns Hopkins University to pursue specialty training in Pulmonary & Critical Care Medicine. He joined the faculty at Emory University in 2005. His main clinical and research interest is pulmonary hypertension. Other interests include critical care medicine, consultative pulmonary medicine, and medical education.
Dr. Fishers main clinical interest is the diagnosis and treatment of pulmonary arterial hypertension. Other interests include critical care medicine and general pulmonary medicine with special emphasis on unexplained shortness of breath.
Dr. Fisher serves as the Associate Director of Pulmonary Hypertension for the McKelvey Lung Transplantation Center and as the Medical Director of the Medical Intensive Care Unit at Emory University Hospital. He is also the co-director of the medical school course in Pulmonary Pathophysiology.
Academic Appointment
- Master Clinician, Emory University School of Medicine
- Assistant Professor of Medicine, Department of Internal Medicine
Education
Degrees
- Post-Baccalaureate from Johns Hopkins University
- Medical Doctor from Wake Forest University School of Medicine
- BA from University of North Carolina at Chapel Hill
- Post-Baccalaureate from University of North Carolina at Chapel Hill
Research
Focus
- My research has focused predominantly on clinical predictors of outcomes and the utility of transthoracic echocardiography for diagnosis and prognostication for patients with pulmonary hypertension.
Publications
-
Seralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.
Lancet Respir Med Volume: 12 Page(s): 523 - 534
07/01/2024 Authors: Frantz RP; McLaughlin VV; Sahay S; Escribano Subas P; Zolty RL; Benza RL; Channick RN; Chin KM; Hemnes AR; Howard LS -
Evaluation of right ventricular strain in two separate cohorts with precapillary pulmonary hypertension.
Pulm Circ Volume: 13 Page(s): e12204
01/01/2023 Authors: Crossman LM; Rajaram P; Hart CM; Pernetz MA; Sahu A; Jokhadar M; Book WM; Fisher MR; Trammell AW -
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI in patients with pulmonary arterial hypertension.
Pulm Circ Volume: 12 Page(s): e12063
04/01/2022 Authors: Spikes LA; Bajwa AA; Burger CD; Desai SV; Eggert MS; El-Kersh KA; Fisher MR; Johri S; Joly JM; Mehta J -
Effect of pulmonary hypertension on 5-year outcome of kidney transplantation.
Pulm Circ Volume: 12 Page(s): e12010
01/08/2022 Authors: Rabih F; Holden RL; Vasanth P; Pastan SO; Fisher MR; Trammell AW -
Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension. A Double-Blind Placebo-controlled Clinical Trial.
Am J Respir Crit Care Med Volume: 201 Page(s): 707 - 717
03/15/2020 Authors: White RJ; Jerjes-Sanchez C; Bohns Meyer GM; Pulido T; Sepulveda P; Wang KY; Grnig E; Hiremath S; Yu Z; Gangcheng Z -
Long-term outcomes in pulmonary arterial hypertension by functional class: a meta-analysis of randomized controlled trials and observational registries.
Pulm Circ Volume: 10 Page(s): 2045894020935291
01/01/2020 Authors: Kim NH; Fisher M; Poch D; Zhao C; Shah M; Bartolome S -
Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study.
J Heart Lung Transplant Volume: 38 Page(s): 43 - 50
01/01/2019 Authors: Frost A; Janmohamed M; Fritz JS; McConnell JW; Poch D; Fortin TA; Miller CE; Chin KM; Fisher M; Eggert M -
The Effects of Pulmonary Hypertension with Left-Sided Heart Disease on Outcomes in Renal Transplant Patients
Volume: 199
01/01/2019 Authors: Holden R; Vasanth P; Trammell A; Fisher MR -
Right Ventricular Longitudinal Peak Strain as a Predictor of Clinical Decompensation: A Single-Center Prospective Study
Volume: 197
01/01/2018 Authors: Rajaram P; White BL; Pernetz MA; Trammell A; Fisher MR -
Chronic Thromboembolic Pulmonary Hypertension: Advances in Therapy.
Semin Respir Crit Care Med Volume: 38 Page(s): 677 - 685
10/01/2017 Authors: Fisher MR; Kim NH